Detecting T cell receptors involved in immune responses from single repertoire snapshots

PLoS Biol. 2019 Jun 13;17(6):e3000314. doi: 10.1371/journal.pbio.3000314. eCollection 2019 Jun.

Abstract

Hypervariable T cell receptors (TCRs) play a key role in adaptive immunity, recognizing a vast diversity of pathogen-derived antigens. Our ability to extract clinically relevant information from large high-throughput sequencing of TCR repertoires (RepSeq) data is limited, because little is known about TCR-disease associations. We present Antigen-specific Lymphocyte Identification by Clustering of Expanded sequences (ALICE), a statistical approach that identifies TCR sequences actively involved in current immune responses from a single RepSeq sample and apply it to repertoires of patients with a variety of disorders - patients with autoimmune disease (ankylosing spondylitis [AS]), under cancer immunotherapy, or subject to an acute infection (live yellow fever [YF] vaccine). We validate the method with independent assays. ALICE requires no longitudinal data collection nor large cohorts, and it is directly applicable to most RepSeq datasets. Its results facilitate the identification of TCR variants associated with diseases and conditions, which can be used for diagnostics and rational vaccine design.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity / genetics*
  • Antigens
  • Antigens, Viral
  • Cluster Analysis
  • Complementarity Determining Regions / genetics*
  • Complementarity Determining Regions / physiology
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • Immunotherapy
  • Receptors, Antigen, T-Cell / immunology
  • Receptors, Antigen, T-Cell / metabolism
  • Receptors, Antigen, T-Cell / physiology*
  • Sequence Analysis, DNA / methods*

Substances

  • Antigens
  • Antigens, Viral
  • Complementarity Determining Regions
  • Receptors, Antigen, T-Cell

Grants and funding

This work was supported by the Russian Science Foundation Grant Number 15-15-00178. MVP is supported by the Skoltech Systems biology fellowship. This work was partially supported by the European Research Council Consolidator Grant Number 724208. DMC and MS were supported by a grant from the Ministry of Education and Science of the Russian Federation Number 14.W03.31.0005 (in part of cancer immunotherapy data analysis). MS is supported by Russian Science Foundation Grant Number 17-15-01495.